Cell Proliferation in Dimethylbenz(A)Anthracene(Dmba)- Induced rat Mammary Carcinoma Treated with Antiestrogen Toremifene

References

• Sutherland R L, Reddel R R, Green M D. Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antiestrogens. Eur J Cancer Clin Oncol 1983; 19: 307–18
   PubMedGoogle Scholar
• Legha S S. Tamoxifen in the treatment of breast cancer. Ann Intern Med 1988; 109: 219–28
   PubMed Web of Science ®Google Scholar
• Lerner L J, Jordan V C. Development of antiestrogens and their use in breast cancer: Eight Cain Memorial Award Lecture. Cancer Res 1990; 50: 4177–89
   PubMed Web of Science ®Google Scholar
• Harris J R, Lippman M E, Veronesi U, Willett W. Breast cancer (Third of three parts). New Engl J Med 1992; 327: 473–80
   PubMed Web of Science ®Google Scholar
• Sutherland R L, Green M D, Hall R E, Reddel R R, Taylor I W. Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0G1, phase of the cell cycle. Eur J Cancer Clin Oncol 1983; 19: 615–21
   PubMedGoogle Scholar
• Osborne C K, Boldt D H, Clark G M, Trent J M. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 1983; 43: 3583–5
   PubMed Web of Science ®Google Scholar
• Osborne C K, Boldt D H, Estrada P. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res 1984; 44: 1433–9
   PubMed Web of Science ®Google Scholar
• Taylor C M, Blanchard B, Zava D T. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Cancer Res 1984; 44: 1409–14
   PubMed Web of Science ®Google Scholar
• Bardon S, Vignon F, Montcourrier P, Rochefort H. Steroid receptor-mediated cyto-toxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res 1987; 47: 1441–8
   PubMed Web of Science ®Google Scholar
• Brünner N, Spang-Thomsen M, Vindeløv Wolff J, Engelholm S A. Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice. Eur J Cancer Clin Oncol 1985; 21: 1349–54
   PubMedGoogle Scholar
• Brünner N, Bronzert D, Vindeløv L L, Rygaard K, Spang-Thomsen M, Lippman M E. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer grown in vitro and in nude mice. Cancer Res 1989; 49: 1515–20
   PubMed Web of Science ®Google Scholar
• Kallio S, Kangas L, Blanco G, et al. A new triphenylethylene compound, Fc-1157a. I. Hormonal effects. Cancer Chemother Pharmacol 1986; 17: 103–8
   PubMed Web of Science ®Google Scholar
• Kangas L, Nieminen A-L, Blanco G, et al. A new triphenylethylene compound, Fc-1157a. II. Antitumor effects. Cancer Chemother Pharmacol 1986; 17: 109–13
   PubMed Web of Science ®Google Scholar
• Valavaara R, Pyrhönen S, Heikkinen M, et al. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study. Eur J Cancer Clin Oncol 1988; 24: 785–90
   PubMedGoogle Scholar
• Stenbygaard L E, Herrstedt J, Thomsen J F, Svendsen K R, Engelholm S A, Dombernowsky P. Toremifene and tamoxifen in advanced breast cancer - a double-blind cross-over trial. Breast Cancer Res Treat 1993; 25: 57–63
   PubMed Web of Science ®Google Scholar
• Vogel C L, Shemano I, Schoenfelder J, Gams R A, Green M R. Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer. J Clin Oncol 1993; 11: 345–50
   PubMed Web of Science ®Google Scholar
• Kangas L. Review of the pharmacological properties of toremifene. J Steroid Biochem 1990; 36: 191–5
   PubMedGoogle Scholar
• Brooks M D, Ebbs S R, Colletta A A, Baum M. Desmoid tumors treated with triphenylethylenes. Eur J Cancer 1992; 28A: 1014–8
   PubMed Web of Science ®Google Scholar
• Robinson S P, Mauel D A, Jordan V C. Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model. Eur J Cancer Clin Oncol 1988; 24: 1817–21
   PubMedGoogle Scholar
• diSalle E, Zaccheo T, Ornati G. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat. J Steroid Biochem 1990; 36: 203–6
   PubMedGoogle Scholar
• Jordan V C. Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifen. J Natl Cancer Inst 1990; 82: 1662–3
   PubMedGoogle Scholar
• Hickmann J A. Apoptosis induced by anticancer drugs. Cancer Metast Rev 1992; 11: 121–39
   PubMed Web of Science ®Google Scholar
• Wärri A M, Huovinen R L, Laine A M, Martikainen P M, Härkönen P L. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 1993; 85: 1412–8
   PubMedGoogle Scholar
• Huovinen R L, Wärri A M, Collan Y. Mitosis, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with antiestrogen toremifene. Int J Cancer 1993; 55: 685–91
   PubMed Web of Science ®Google Scholar
• Grenman R, Laine K-M, Klemi P J, Grenman S, Hayashida D JS, Joensuu H. Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7. J Cancer Res Clin Oncol 1991; 117: 223–6
   PubMed Web of Science ®Google Scholar
• Huggins C, Yang N C. Induction and extinction of mammary cancer. Science 1962; 137: 257–62
   PubMed Web of Science ®Google Scholar
• Haapasalo H, Pesonen E, Collan Y. Volume corrected mitotic index (M/V INDEX). Path Res Pract 1989; 185: 551–4
   PubMed Web of Science ®Google Scholar
• Archer F L, Orlando R A. Morphology, natural history, and enzyme patterns in mammary tumors of the rat induced by 7,12-dimethylbenz(a)anthracene. Cancer Res 1968; 28: 217–24
   PubMed Web of Science ®Google Scholar
• Alanen K A, Klemi P J, Joensuu H, Kujari H, Pekkala E. Comparison of fresh, ethanol preserved, and paraffin embedded samples in DNA flow cytometry. Cytometry 1989; 10: 81–5
   PubMedGoogle Scholar
• Vindeløv L L, Chistensen I J, Nissen N I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–7
   PubMedGoogle Scholar
• Baisch H, Göhde W, Linden W A. Analysis of PCP-data to determine the fraction of cells in the various phases of the cell cycle. Radiat Environ Biophys 1975; 12: 31–9
   PubMed Web of Science ®Google Scholar
• Jordan V C. Laboratory models of breast cancer to aid the elucidation of antiestrogen action. J Lab Clin Med 1987; 109: 267–77
   PubMed Web of Science ®Google Scholar
• Nicholson R I, Kéri G. Antitumor activity of Folligen, a novel gonadotropin-releasing hormone analogue against DMBA-in- duced tumours in the rat. Tumor Biol 1992; 13: 44–50
   PubMedGoogle Scholar
• Baak J PA. Mitosis counting in tumors. Hum Pathol 1990; 21: 683–4
   PubMed Web of Science ®Google Scholar
• Hall P A, Levison D A. Review: Assessment of cell proliferation in histological material. J. Clin Pathol 1990; 43: 184–92
   PubMed Web of Science ®Google Scholar
• Young S, Hallowes R C. Tumours to the mammary gland. Pathology of tumours in laboratory animals. 1973; Vol 1: 31–74
   Google Scholar
• Colombel M, Olsson C A, Ng P-Y, Buttyan R. Homone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 1992; 52: 4313–9
   PubMed Web of Science ®Google Scholar